INS and diabetes mellitus: The possibility of providing dual mechanisms of reduced blood glucose via phytocannabinoid treatment, by both improved insulin sensitivity and glucose clearance as well as decreased SGLT2 transporter activity and renal glucose reabsorption, could serve as a comprehensive diabetes treatment.